ID   SNUT1_RAT               Reviewed;         806 AA.
AC   Q5XIW8; Q9Z314;
DT   07-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   29-MAY-2024, entry version 120.
DE   RecName: Full=U4/U6.U5 tri-snRNP-associated protein 1;
DE   AltName: Full=Squamous cell carcinoma antigen recognized by T-cells 1;
DE            Short=SART-1;
DE            Short=rSART-1;
GN   Name=Sart1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=9765622; DOI=10.1111/j.1349-7006.1998.tb00639.x;
RA   Gotoh M., Shichijo S., Hoshino T., Imai Y., Imaizumi T., Inoue Y.,
RA   Takasu H., Yamaoka T., Itoh K.;
RT   "Sequence analysis of genes encoding rodent homologues of the human tumor-
RT   rejection antigen SART-1.";
RL   Jpn. J. Cancer Res. 89:849-854(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-481; SER-597; SER-602 AND
RP   SER-604, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Plays a role in mRNA splicing as a component of the U4/U6-U5
CC       tri-snRNP, one of the building blocks of the spliceosome. May also bind
CC       to DNA. {ECO:0000250|UniProtKB:O43290}.
CC   -!- SUBUNIT: Identified in the spliceosome C complex. Component of the
CC       U4/U6-U5 tri-snRNP complex composed of the U4, U6 and U5 snRNAs and at
CC       least PRPF3, PRPF4, PRPF6, PRPF8, PRPF31, SNRNP200, TXNL4A, SNRNP40,
CC       DDX23, CD2BP2, PPIH, SNU13, EFTUD2, SART1 and USP39. Interacts with
CC       UBL5. {ECO:0000250|UniProtKB:O43290}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O43290}.
CC       Note=Found in the nucleus of mitogen-activated peripheral blood
CC       mononuclear cells (PBMCs), tumor cells, or normal cell lines, but not
CC       in normal tissues except testis and fetal liver or in unstimulated
CC       PBMCs, suggesting preferential expression in proliferating cells.
CC       {ECO:0000250|UniProtKB:O43290}.
CC   -!- PTM: Sumoylated with SUMO2. {ECO:0000250|UniProtKB:O43290}.
CC   -!- SIMILARITY: Belongs to the SNU66/SART1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB014722; BAA36584.1; -; mRNA.
DR   EMBL; BC083551; AAH83551.1; -; mRNA.
DR   RefSeq; NP_113784.1; NM_031596.1.
DR   AlphaFoldDB; Q5XIW8; -.
DR   SMR; Q5XIW8; -.
DR   STRING; 10116.ENSRNOP00000027812; -.
DR   iPTMnet; Q5XIW8; -.
DR   PhosphoSitePlus; Q5XIW8; -.
DR   jPOST; Q5XIW8; -.
DR   PaxDb; 10116-ENSRNOP00000027812; -.
DR   Ensembl; ENSRNOT00000027811.4; ENSRNOP00000027812.1; ENSRNOG00000020475.4.
DR   Ensembl; ENSRNOT00055036290; ENSRNOP00055029482; ENSRNOG00055021226.
DR   Ensembl; ENSRNOT00065057868; ENSRNOP00065047653; ENSRNOG00065033679.
DR   GeneID; 29678; -.
DR   KEGG; rno:29678; -.
DR   UCSC; RGD:61930; rat.
DR   AGR; RGD:61930; -.
DR   CTD; 9092; -.
DR   RGD; 61930; Sart1.
DR   eggNOG; KOG2217; Eukaryota.
DR   GeneTree; ENSGT00390000007071; -.
DR   HOGENOM; CLU_009379_3_0_1; -.
DR   InParanoid; Q5XIW8; -.
DR   OMA; DTQMQKV; -.
DR   OrthoDB; 24344at2759; -.
DR   PhylomeDB; Q5XIW8; -.
DR   TreeFam; TF318828; -.
DR   Reactome; R-RNO-72163; mRNA Splicing - Major Pathway.
DR   PRO; PR:Q5XIW8; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000020475; Expressed in thymus and 20 other cell types or tissues.
DR   GO; GO:0015030; C:Cajal body; ISO:RGD.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0016607; C:nuclear speck; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0071005; C:U2-type precatalytic spliceosome; ISO:RGD.
DR   GO; GO:0046540; C:U4/U6 x U5 tri-snRNP complex; ISO:RGD.
DR   GO; GO:0000481; P:maturation of 5S rRNA; IBA:GO_Central.
DR   GO; GO:0045292; P:mRNA cis splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; ISO:RGD.
DR   GO; GO:0045585; P:positive regulation of cytotoxic T cell differentiation; ISO:RGD.
DR   InterPro; IPR045347; HIND.
DR   InterPro; IPR005011; SNU66/SART1.
DR   PANTHER; PTHR14152; SQUAMOUS CELL CARCINOMA ANTIGEN RECOGNISED BY CYTOTOXIC T LYMPHOCYTES; 1.
DR   PANTHER; PTHR14152:SF5; U4_U6.U5 TRI-SNRNP-ASSOCIATED PROTEIN 1; 1.
DR   Pfam; PF19252; HIND; 1.
DR   Pfam; PF03343; SART-1; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Isopeptide bond; mRNA processing; mRNA splicing; Nucleus;
KW   Phosphoprotein; Reference proteome; Spliceosome; Ubl conjugation.
FT   CHAIN           1..806
FT                   /note="U4/U6.U5 tri-snRNP-associated protein 1"
FT                   /id="PRO_0000223310"
FT   REGION          1..121
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          418..505
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          578..610
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          157..231
FT                   /evidence="ECO:0000255"
FT   COILED          495..540
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        44..104
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        434..452
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        582..602
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         189
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z315"
FT   MOD_RES         321
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   MOD_RES         348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   MOD_RES         431
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   MOD_RES         481
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         527
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   MOD_RES         597
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         602
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         604
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         627
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   MOD_RES         701
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   MOD_RES         767
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   MOD_RES         770
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   MOD_RES         795
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        125
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        133
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        141
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        141
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        147
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        188
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        277
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        329
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        336
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        400
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        414
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        554
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        654
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        663
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        690
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        705
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        715
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        729
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        755
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        764
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        781
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        786
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CROSSLNK        797
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O43290"
FT   CONFLICT        317
FT                   /note="A -> V (in Ref. 1; BAA36584)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   806 AA;  91011 MW;  C8A1BCADC07544E9 CRC64;
     MGSSKKHRGE KEAAGTTAAA GTGGTTEQPP RHREHKKHKH RSSGGGSSGG ERRKRSRERG
     AERGSGRRGA EAEARSGAHG RERSQAEPSE RRVKREKRDE GYEAAASSKA SSGDASSLSI
     EETNKLRAKL GLKPLEVNAV KKEAGTKEEP VAADVINPMA LRQREELREK LAAAKEKRLL
     NQKLGKIKTL GEDDPWLDDT AAWIERSRQL QKEKDLAEKR AKLLEEMDQE FGVSTLVEEE
     FEQRRQDLYS ARDLQGLTVE HAIDSFREGE TVVLTLKDKG VLQEGEDVLV NVNMVDKERA
     DKNVELRKKK PDYLPYAEDE SVDDLAQQKP RSILAKYDEE LEGERPHSFR LEQGGMADGL
     RERELEEIRT KLRLQAQSLN TVGPRLASEY LSPEEMVTFK KTKRRVKKIR KKEKEVIMRA
     DDLLPLGEDQ TQDGDFGSRL RGRGRRRVPE VEEEALEDEE KDPVAQPPPS DDTRVENMDI
     SDEEDGGALP SGPPELEEDE AELELQKQLE KGRRLRQLQQ LQQLRDSGEK VLEIVKKLES
     RQRGWEEEED PERKGTIVFN ATSEFCRTLG EIPTYGLAGN REEQEELMDF ERDEERSANG
     GSESDGEENI GWSTVNLDEE KQHQDFSASS TTILDEEPIV NRGLAAALLL CQNKGLLETT
     VQKVARVKAP NKSLPSAVYC IEDKMAIDDK YSRREEYRGF TQDFKEKDGY KPDVKIEYVD
     ETGRKLTPKE AFRQLSHRFH GKGSGKMKTE RRMKKLDEEA LLKKMSSSDT PLGTVALLQE
     KQKAQKTPYI VLSGSGKSMN ANTITK
//
